Editorial | Hong Kong has what it takes to be a medical hub
- City has the expertise – and connections with mainland China – to be a serious and world-leading player in the biomedical industry
Hong Kong’s potential for becoming a super connector with the world for the mainland is not limited to business and investment.
It is to be found, for example, in the push to become a health and medical innovation hub, building on a world-class health system and a solid academic research base.
It was once envisaged that the city could become a medical tourism hub – for those who could afford it. Now it aspires to be a centre for clinical trials of drugs and treatments that could benefit all of mankind.
In his policy address, Chief Executive John Lee Ka-chiu announced the establishment of a clinical trial institute in the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone.
16:01
The ‘hits’ and ‘misses’ of John Lee’s 2023 policy address
It will be a one-stop clinical trial support platform for medical research institutions and a step towards Hong Kong’s aim to develop its own drug approval system for international reference.